DENTSPLY SIRONA (NASDAQ:XRAY) Announces Earnings Results

DENTSPLY SIRONA (NASDAQ:XRAY) posted its quarterly earnings data on Thursday. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42, RTT News reports. The firm had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.39 earnings per share. DENTSPLY SIRONA updated its FY24 guidance to $2.00-$2.10 EPS.

DENTSPLY SIRONA Trading Down 0.3 %

Shares of XRAY stock opened at $28.29 on Friday. The company has a market cap of $5.87 billion, a PE ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. DENTSPLY SIRONA has a 1 year low of $26.27 and a 1 year high of $41.65. The stock’s 50 day simple moving average is $32.13 and its two-hundred day simple moving average is $32.71. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.95.

DENTSPLY SIRONA Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 annualized dividend and a yield of 2.26%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on XRAY. Leerink Partnrs reaffirmed an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Piper Sandler restated a “neutral” rating and set a $32.00 price objective (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a report on Friday. Barrington Research decreased their price target on DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Evercore ISI dropped their price objective on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $36.90.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.